(Q35855101)

10 August 2017

The gut microbiome, diet, and links to cardiometabolic and chronic disorders (English)

1 reference

10 August 2017

0 references

2

Karine Clément

1 reference

PubMed ID

26616538

10 August 2017

Judith Aron-Wisnewsky

series ordinal

1

object named as

Judith Aron-Wisnewsky

1 reference

PubMed ID

26616538

10 August 2017

language of work or name

English

0 references

publication date

30 November 2015

1 reference

Nature Reviews Nephrology

10 August 2017

1 reference

10 August 2017

12

1 reference

10 August 2017

169-181

1 reference

10 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2015.191

10 August 2017

0 references

cites work

Prevalence of obesity in the United States

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Obesity as a medical problem

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Healthy lifestyle interventions to combat noncommunicable disease-a novel nonhierarchical connectivity model for key stakeholders: a policy statement from the American Heart Association, European Society of Cardiology, European Association for Cardi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

The human microbiome project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

The impact of the gut microbiota on human health: an integrative view

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

The importance of the gut microbiota after bariatric surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Next-generation DNA sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

An integrated catalog of reference genes in the human gut microbiome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

What has high-throughput sequencing ever done for us?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

New insights into the impact of the intestinal microbiota on health and disease: a symposium report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

From next-generation sequencing to systematic modeling of the gut microbiome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Processing faecal samples: a step forward for standards in microbial community analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Storage conditions of intestinal microbiota matter in metagenomic analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Microbiota—implications for immunity and transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

The gut microbiota as an environmental factor that regulates fat storage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

An obesity-associated gut microbiome with increased capacity for energy harvest

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Gut microbiota from twins discordant for obesity modulate metabolism in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Glycan foraging in vivo by an intestine-adapted bacterial symbiont

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Metagenomic analysis of the human distal gut microbiome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

In vitro characterization of the impact of different substrates on metabolite production, energy extraction and composition of gut microbiota from lean and obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Microbiota metabolite regulation of host immune homeostasis: a mechanistic missing link

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

How informative is the mouse for human gut microbiota research?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Human gut microbiome viewed across age and geography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Dietary intervention impact on gut microbial gene richness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Gut microbiota composition correlates with diet and health in the elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Enterotypes of the human gut microbiome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

A metagenome-wide association study of gut microbiota in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Symptomatic atherosclerosis is associated with an altered gut metagenome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Linking long-term dietary patterns with gut microbial enterotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Dietary history contributes to enterotype-like clustering and functional metagenomic content in the intestinal microbiome of wild mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Rethinking "enterotypes".

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Categorization of the gut microbiota: enterotypes or gradients?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

A core human microbiome as viewed through 16S rRNA sequence clusters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Dietary effects on human gut microbiome diversity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Diet and the development of the human intestinal microbiome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Responses of gut microbiota to diet composition and weight loss in lean and obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Diet rapidly and reproducibly alters the human gut microbiome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Dominant and diet-responsive groups of bacteria within the human colonic microbiota

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Human colonic microbiota associated with diet, obesity and weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Metabolic endotoxemia initiates obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

CD14 modulates inflammation-driven insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Intestinal permeability is associated with visceral adiposity in healthy women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Intestinal permeability--a new target for disease prevention and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Microbial modulation of insulin sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Microbiota and diabetes: an evolving relationship.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Functional interactions between the gut microbiota and host metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Gut microbiome, obesity, and metabolic dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Richness of human gut microbiome correlates with metabolic markers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Human gut microbiota in obesity and after gastric bypass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Expression of the short-chain fatty acid receptor, GPR43, in the human colon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Human genetics shape the gut microbiome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Gut metagenome in European women with normal, impaired and diabetic glucose control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Human gut microbiota changes reveal the progression of glucose intolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Bariatric surgery and long-term cardiovascular events.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

How do we define cure of diabetes?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Transcriptomic fingerprinting of Pseudomonas putida under alternative physiological regimes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Duodenal infusion of donor feces for recurrent Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Human oral, gut, and plaque microbiota in patients with atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

The contributory role of gut microbiota in cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Dietary modification of the microbiome affects risk for cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Gut microbiota: an environmental risk factor for cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Transmission of atherosclerosis susceptibility with gut microbial transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Fish consumption and the 30-year risk of fatal myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Gut microbiota metabolism of L-carnitine and cardiovascular risk.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Effective dosing of L-carnitine in the secondary prevention of cardiovascular disease: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Chronic kidney disease alters intestinal microbial flora

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Inflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate Modeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Gut bacterial translocation may aggravate microinflammation in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Gut microbial translocation in the pathogenesis of systemic inflammation in patients with end-stage renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Changes in intestinal permeability after Roux-en-Y gastric bypass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Increased intestinal permeability to differently sized polyethylene glycols in uremic rats: effects of low- and high-protein diets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

TMAO is both a biomarker and a renal toxin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Oral L-carnitine: metabolite formation and hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Cystatin C: a kidney function biomarker

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Cystatin C for glomerular filtration rate estimation: coming of age

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

The human gut microbiota and virome: Potential therapeutic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Gut inflammation and immunity: what is the role of the human gut virome?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

The human gut virome: inter-individual variation and dynamic response to diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Antibiotic treatments and microbes in the gut.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

The effect of PPI use on human gut microbiota and weight loss in patients undergoing laparoscopic Roux-en-Y gastric bypass.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Influence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Roux-en-Y gastric bypass surgery in rats alters gut microbiota profile along the intestine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

Fecal microbiota analysis: an overview of sample collection methods and sequencing strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2015.191

High-density lipoprotein-based drug discovery for treatment of atherosclerosis

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26616538

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26616538

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEPH.2015.191

1 reference

10 August 2017

1 reference

PubMed ID

26616538